Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

Clinical trial NCT02101788 · COMPLETED

Trial details

NCT number: NCT02101788
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Borderline Ovarian Serous Tumor Micropapillary Serous Carcinoma Ovarian Serous Adenocarcinoma Primary Peritoneal Serous Adenocarcinoma Recurrent Ovarian Low Grade Serous Adenocarcinoma Recurrent Primary Peritoneal Serous Adenocarcinoma

Start date: 2014-04-11
Primary completion: 2019-04-04
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.